MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
Acasti Pharma P/CF Ratio 2011-2026 | ACST
Annual P/CF Ratio Acasti Pharma
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.73 | -2.6 | -1.54 | -1.18 | -1.04 | -35 | -1.9 | -1.34 | -1.9 K | -3.14 | -8.75 | -15.5 | -59.8 | -25 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -1.04 | -1.9 K | -147 |
P/CF Ratio of other stocks in the Biotechnology industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M |  Germany |
 |
Aeterna Zentaris
AEZS
|
-4.82 | - | 5.93 % | $ 314 M |  Canada |
 |
Adagene
ADAG
|
-2.96 | $ 1.9 | -3.11 % | $ 107 M |  China |
 |
Acorda Therapeutics
ACOR
|
-1.2 | - | -24.86 % | $ 820 K |  USA |
 |
AgeX Therapeutics
AGE
|
-0.0018 | - | -10.17 % | $ 12.2 K | USA |
 |
Aytu BioScience
AYTU
|
-8.14 | $ 2.71 | 1.88 % | $ 17 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
6.13 | $ 25.87 | -0.79 % | $ 1.25 B | USA |
 |
Alterity Therapeutics Limited
ATHE
|
-94.9 | $ 3.31 | -4.06 % | $ 7.96 B |  Australia |
 |
Aptose Biosciences
APTO
|
-0.0645 | - | -45.71 % | $ 1.2 M | Canada |
 |
Aravive
ARAV
|
-0.928 | - | -13.39 % | $ 1.45 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | USA |
 |
AVROBIO
AVRO
|
-0.891 | - | 1083.1 % | $ 745 M | USA |
 |
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M |  France |
 |
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | USA |
 |
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | USA |
 |
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B | USA |
 |
Brickell Biotech
BBI
|
-2.62 | - | -5.38 % | $ 6.06 M | USA |
 |
BioLineRx Ltd.
BLRX
|
-57.4 | $ 2.97 | 3.12 % | $ 908 M |  Israel |
 |
BeiGene, Ltd.
BGNE
|
-1.8 K | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Akouos
AKUS
|
-2.7 | - | 0.23 % | $ 488 M | USA |
 |
Applied Molecular Transport
AMTI
|
-0.236 | - | - | $ 10.1 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - |  Russia |
 |
Ascendis Pharma A/S
ASND
|
-17.6 | $ 215.29 | 4.59 % | $ 5 B |  Danmark |
 |
BioNTech SE
BNTX
|
70.7 | $ 105.97 | -2.78 % | $ 27.2 B | Germany |
 |
Bellicum Pharmaceuticals
BLCM
|
-0.323 | - | -9.72 % | $ 5.89 M | USA |
 |
ARCA biopharma
ABIO
|
-8.36 | - | 1052.0 % | $ 415 M | USA |
 |
Bio-Path Holdings
BPTH
|
-0.255 | - | - | $ 100 K | USA |
 |
Baudax Bio
BXRX
|
-0.028 | - | 0.59 % | $ 63 K | USA |
 |
Arrowhead Pharmaceuticals
ARWR
|
34.8 | $ 64.74 | 1.41 % | $ 8.66 B | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-413 | $ 3.96 | -1.0 % | $ 8.62 B | Israel |
 |
Burford Capital Limited
BUR
|
11.6 | $ 9.63 | -0.93 % | $ 1.56 B | Britain |
 |
CASI Pharmaceuticals
CASI
|
-40.6 | $ 0.95 | -0.72 % | $ 129 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
-0.224 | - | - | $ 7.46 M | Israel |
 |
Adaptimmune Therapeutics plc
ADAP
|
-14.6 | - | -15.15 % | $ 60.3 M | Britain |
 |
Celldex Therapeutics
CLDX
|
-0.00833 | $ 25.15 | -1.95 % | $ 1.62 M | USA |
 |
AIkido Pharma
AIKI
|
-1.3 | - | 1.93 % | $ 17.4 M | USA |
 |
Albireo Pharma
ALBO
|
-5 | - | -0.23 % | $ 916 M | USA |
 |
CureVac N.V.
CVAC
|
-4.82 | - | - | $ 867 M | Germany |
 |
Acer Therapeutics
ACER
|
-0.401 | - | 2.71 % | $ 14 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-6.14 | - | - | $ 2.17 B | USA |
 |
AlloVir
ALVR
|
-0.723 | - | 4.14 % | $ 49.1 M | USA |
 |
Catalyst Biosciences
CBIO
|
1.3 | $ 14.01 | 3.7 % | $ 922 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-0.0776 | - | -11.43 % | $ 502 K | USA |
 |
Biogen
BIIB
|
6.73 | $ 164.87 | 0.27 % | $ 24 B | USA |
 |
Avid Bioservices
CDMO
|
38.7 | - | - | $ 789 M | USA |
 |
BioVie
BIVI
|
-0.128 | $ 1.23 | 2.07 % | $ 1.82 M | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
10.2 | $ 23.32 | 2.71 % | $ 2.76 B | USA |
 |
Calithera Biosciences
CALA
|
-14.5 | - | -10.95 % | $ 876 K | USA |